Serial Number | 98914487 |
Word Mark | ANTINOL PLUS |
Filing Date | Friday, December 20, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, August 12, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 2, 2025 |
Goods and Services | Natural medicines for animals containing extracts from shellfish for treating inflammation; natural medicines for animals containing extracts from shellfish for treating arthritis; natural medicines for animals containing extracts from shellfish for treating arthritic pain; natural medicines for animals containing extracts from shellfish for treating skin disorders; veterinary preparations for animals containing extracts from shellfish for treating inflammation; veterinary preparations for animals containing extracts from shellfish for treating arthritis; veterinary preparations for animals containing extracts from shellfish for treating arthritic pain; veterinary preparations for animals containing extracts from shellfish for treating skin disorders; biological preparations for veterinary purposes for treating inflammation; biological preparations for veterinary purposes for treating arthritis; biological preparations for veterinary purposes for treating arthritic pain; biological preparations for veterinary purposes for treating skin disorders; veterinary preparations for animals for treatment of inflammatory conditions; veterinary preparations for animals for treatment of arthritis; veterinary preparations for animals for treatment of arthritic pain; veterinary preparations for animals for treatment of skin disorders; veterinary medicines for treatment of inflammatory conditions; veterinary medicines for treatment of arthritis; veterinary medicines for treatment of arthritic pain; veterinary medicines for treatment of skin disorders; dietetic substances in the nature of extracts from crustaceans and shellfish adapted for veterinary use; dietetic substances in the nature of extracts from crustaceans and shellfish used as an anti-inflammatory; natural medicines for treatment of arthritis; natural medicines for treatment of arthritic pain; natural medicines for treatment of skin disorders; dietetic veterinary substances in the nature of extracts from crustaceans and shellfish for anti-inflammatory use; medical nutritious food additives in the nature of natural food extracts derived from crustaceans and shellfish for animals; minerals being nutritional additives for medical animal food; vitamins being nutritional additives for medical animal food; dietary supplements for animals; nutritional supplements for animals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 20, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Pharmalink International Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Central HK |
Event Date | Event Description |
Friday, December 20, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, June 6, 2025 | ASSIGNED TO EXAMINER |
Friday, December 20, 2024 | NEW APPLICATION ENTERED |
Monday, June 9, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 9, 2025 | NON-FINAL ACTION E-MAILED |
Monday, June 9, 2025 | NON-FINAL ACTION WRITTEN |
Monday, July 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 28, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, July 29, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, July 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |